These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 9203654)
41. Development of candidate rotavirus vaccines. Bishop RF Vaccine; 1993; 11(2):247-54. PubMed ID: 8382418 [TBL] [Abstract][Full Text] [Related]
42. Molecular cloning and immunogenicity evaluation of rotavirus structural proteins as candidate vaccine. El-Senousy WM; Shahein YE; Barakat AB; Ghanem HE; El-Hakim AE; Ameen SM Int J Biol Macromol; 2013 Aug; 59():67-71. PubMed ID: 23588003 [TBL] [Abstract][Full Text] [Related]
43. Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge. Mackow ER; Vo PT; Broome R; Bass D; Greenberg HB J Virol; 1990 Apr; 64(4):1698-703. PubMed ID: 2157052 [TBL] [Abstract][Full Text] [Related]
44. Identification of VP7 epitopes associated with protection against human rotavirus illness or shedding in volunteers. Green KY; Kapikian AZ J Virol; 1992 Jan; 66(1):548-53. PubMed ID: 1370092 [TBL] [Abstract][Full Text] [Related]
45. Neutralization of rotavirus and recognition of immunologically important epitopes on VP4 and VP7 by human IgA. Johansen K; Svensson L Arch Virol; 1997; 142(7):1491-8. PubMed ID: 9267458 [TBL] [Abstract][Full Text] [Related]
46. Polypeptide specificity of antiviral serum antibodies in children naturally infected with human rotavirus. Brüssow H; Offit PA; Gerna G; Bruttin A; Sidoti J J Virol; 1990 Sep; 64(9):4130-6. PubMed ID: 2166808 [TBL] [Abstract][Full Text] [Related]
47. Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination. McNeal MM; Broome RL; Ward RL Virology; 1994 Nov; 204(2):642-50. PubMed ID: 7941332 [TBL] [Abstract][Full Text] [Related]
48. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection. Parez N; Fourgeux C; Mohamed A; Dubuquoy C; Pillot M; Dehee A; Charpilienne A; Poncet D; Schwartz-Cornil I; Garbarg-Chenon A J Virol; 2006 Feb; 80(4):1752-61. PubMed ID: 16439532 [TBL] [Abstract][Full Text] [Related]
49. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice. Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020 [TBL] [Abstract][Full Text] [Related]
50. Homotypic and heterotypic immune responses to group A rotaviruses in parenterally immunized sheep. Beards GM; King JA; Mazhar S; Landon J; Desselberger U Vaccine; 1993; 11(2):262-6. PubMed ID: 8382420 [TBL] [Abstract][Full Text] [Related]
51. Viral proteins VP2, VP6, and NSP2 are strongly precipitated by serum and fecal antibodies from children with rotavirus symptomatic infection. Colomina J; Gil MT; Codoñer P; Buesa J J Med Virol; 1998 Sep; 56(1):58-65. PubMed ID: 9700634 [TBL] [Abstract][Full Text] [Related]
52. Quantification of systemic and local immune responses to individual rotavirus proteins during rotavirus infection in mice. Ishida S; Feng N; Tang B; Gilbert JM; Greenberg HB J Clin Microbiol; 1996 Jul; 34(7):1694-700. PubMed ID: 8784572 [TBL] [Abstract][Full Text] [Related]
53. Resistance to rotavirus infection in adult volunteers challenged with a virulent G1P1A[8] virus correlated with serum immunoglobulin G antibodies to homotypic viral proteins 7 and 4. Yuan L; Honma S; Kim I; Kapikian AZ; Hoshino Y J Infect Dis; 2009 Nov; 200(9):1443-51. PubMed ID: 19785527 [TBL] [Abstract][Full Text] [Related]
54. Protein-energy malnutrition alters IgA responses to rotavirus vaccination and infection but does not impair vaccine efficacy in mice. Maier EA; Weage KJ; Guedes MM; Denson LA; McNeal MM; Bernstein DI; Moore SR Vaccine; 2013 Dec; 32(1):48-53. PubMed ID: 24200975 [TBL] [Abstract][Full Text] [Related]
55. Construction of four double gene substitution human x bovine rotavirus reassortant vaccine candidates: each bears two outer capsid human rotavirus genes, one encoding P serotype 1A and the other encoding G serotype 1, 2, 3, or 4 specificity. Hoshino Y; Jones RW; Chanock RM; Kapikian AZ J Med Virol; 1997 Apr; 51(4):319-25. PubMed ID: 9093947 [TBL] [Abstract][Full Text] [Related]
56. The internal rotavirus protein VP6 primes for an enhanced neutralizing antibody response. Esquivel FR; Lopez S; Guitierrez-X L; Arias C Arch Virol; 2000; 145(4):813-25. PubMed ID: 10893159 [TBL] [Abstract][Full Text] [Related]
57. Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody. Ward RL; McNeal MM; Sheridan JF Virology; 1992 May; 188(1):57-66. PubMed ID: 1314467 [TBL] [Abstract][Full Text] [Related]
58. Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. Kapikian AZ; Hoshino Y; Chanock RM; Pérez-Schael I J Infect Dis; 1996 Sep; 174 Suppl 1():S65-72. PubMed ID: 8752293 [TBL] [Abstract][Full Text] [Related]
59. Maternal antibody-mediated protection against gastroenteritis due to rotavirus in newborn mice is dependent on both serotype and titer of antibody. Offit PA; Clark HF J Infect Dis; 1985 Dec; 152(6):1152-8. PubMed ID: 2999254 [TBL] [Abstract][Full Text] [Related]
60. Sequential administration of two human-rhesus rotavirus reassortant strains of VP7 serotype 1 and 2 specificity to infants and young children. Kobayashi M; Araki K; Thompson J; Tollefson SJ; Wright PF J Infect Dis; 1993 Mar; 167(3):748-52. PubMed ID: 8382725 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]